JUNO
Juno Therapeutics, Inc.
JUNO
JUNO
Delisted
JUNO was delisted on the 5th of March, 2018.
210 hedge funds and large institutions have $3.62B invested in Juno Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 64 increasing their positions, 55 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
210
Holders Change
+37
Holders Change %
+21.39%
% of All Funds
5.24%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.17%
New
59
Increased
64
Reduced
55
Closed
22
Calls
$63.4M
Puts
$71.6M
Net Calls
-$8.23M
Net Calls Change
+$5.97M
Top Buyers
| 1 |
Capital International Investors
Los Angeles,
California
|
$256M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
$65.1M |
| 3 |
Jennison Associates
New York
|
$89.2M |
| 4 |
O
OrbiMed
New York
|
$91.6M |
| 5 |
D.E. Shaw & Co
New York
|
$42.9M |
